Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Form 8.3 - [AorTech Inter PLC]

23 Jul 2012 13:46

RNS Number : 2715I
Clive Titcomb
23 July 2012
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Clive Titcomb

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aortech PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

56,000

1.16

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

56,000

1.16

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23 July 2012

Contact name:

Clive Titcomb

Telephone number:

07917-686444

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETSEIFEDFESEDW
Date   Source Headline
9th Oct 20131:55 pmRNSDirector/PDMR Shareholding
8th Oct 20132:56 pmRNSDirector/PDMR Shareholding
8th Oct 20137:00 amRNSSettlement of Legal Proceedings
1st Oct 20138:18 amRNSNew Manufacture License
27th Sep 20138:37 amRNSResult of AGM
28th Aug 20137:00 amRNSFinal Results
23rd May 201312:23 pmRNSUpdate and appointment of director
20th Mar 20139:39 amRNSCommencement of legal proceedings
27th Dec 20127:00 amRNSHalf Yearly Report
24th Dec 20128:35 amRNSDispute with St Jude Medical resolved
5th Nov 20121:31 pmRNSUpdate re litigation
26th Oct 20123:47 pmRNSIssue of loan notes
22nd Oct 20129:15 amRNSUpdate
19th Oct 20122:43 pmRNSUpdate re St Jude
18th Oct 20124:39 pmRNSUpdate re St Jude
9th Oct 20128:02 amRNSRe Agreement
28th Sep 201211:29 amRNSUpdate
10th Sep 20122:51 pmRNSForm 8.3 - AorTech Inter PLC
4th Sep 20127:00 amRNSFinal Results
13th Aug 201210:03 amRNSUpdate on sale process
26th Jul 20125:16 pmRNSForm 8.3 - AorTech International plc
23rd Jul 20123:08 pmRNSForm 8 (OPD) (AorTech International Plc)
23rd Jul 20121:46 pmRNSForm 8.3 - [AorTech Inter PLC]
18th Jul 201210:53 amRNSForm 8.3 - AorTech International PLC
13th Jul 201210:37 amRNSForm 8.3 - [AorTech Inter PLC]
12th Jul 20122:06 pmRNSForm 8.3 - AorTech International PLC
11th Jul 20124:06 pmRNSForm 8.3 - AorTech International PLC
10th Jul 20123:04 pmRNSForm 8.3 - [AorTech International PLC]
10th Jul 201212:09 pmRNSForm 8.3 - Aortech Intl Plc
10th Jul 201212:08 pmRNSForm 8.3 Aortech Intl Plc
10th Jul 201211:54 amRNSForm 8 (OPD) Aortech Intl Plc
10th Jul 201210:38 amRNSForm 8.3 - [AorTech International PLC]
4th Jul 20122:06 pmRNSForm 8.3 - Aortech International plc
4th Jul 20121:23 pmRNSForm 8.3 - Aortech International Plc
3rd Jul 20127:00 amRNSBoard Change & Strategic Update
23rd Apr 20127:00 amRNSChange of Nominated Adviser
6th Mar 20123:30 pmRNSAorTech Announces Update of Factory Move
25th Jan 20123:08 pmRNSHolding(s) in Company
14th Dec 201110:48 amRNSAorTech Announces Interim Report (Replacement)
14th Dec 20117:00 amRNSAorTech Announces Interim Report
18th Nov 20117:00 amRNSAorTech Announces Exclusive Licence in New Field
21st Oct 20117:00 amRNSDirectorate Change
9th Sep 20117:00 amRNSResult of AGM
8th Sep 20119:30 amRNSAorTech Announces Breast Implant Agreement
18th Aug 20115:00 pmRNSNotice of AGM
15th Aug 20116:03 pmRNSDirector/PDMR Shareholding
3rd Aug 20117:00 amRNSDirectorate Change
1st Aug 20117:00 amRNSAorTech Announces Year End Preliminary Results
16th Jun 20117:00 amRNSAorTech to Open US Facility
20th May 20119:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.